Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/23/2026

Mammographic Asymmetry Evaluation Guidelines

Diagnostic Approach

  • The National Comprehensive Cancer Network recommends diagnostic mammography with additional views (spot compression, magnification) to better characterize the asymmetry, followed by targeted ultrasound of the area of concern 1, 2
  • Diagnostic mammography with additional views (spot compression, magnification) is used to characterize the asymmetry, as recommended by the American College of Radiology 3, 1
  • Targeted ultrasound of the area of concern should be performed concurrently with diagnostic mammography, as suggested by the National Comprehensive Cancer Network 1, 2

BI-RADS Assessment and Follow-up

  • For BI-RADS 1-3 (Negative, Benign, or Probably Benign) cases, the National Comprehensive Cancer Network recommends clinical re-examination in 3-6 months, and follow-up imaging with diagnostic mammogram and/or ultrasound every 6-12 months for 1-2 years to assess stability 1, 2
  • If stable, the National Comprehensive Cancer Network suggests returning to routine screening 1
  • For BI-RADS 4-5 (Suspicious or Highly Suggestive of Malignancy) cases, tissue biopsy using core needle biopsy (preferred) or needle localization excisional biopsy is recommended by the National Comprehensive Cancer Network 2, 4

Imaging Techniques

  • Magnification views are particularly helpful for evaluating any associated microcalcifications, as noted by the American College of Radiology 3

Mammographic Asymmetry and Cancer Risk Assessment

Diagnostic Approach

  • The American College of Radiology recommends diagnostic mammography with spot compression and magnification views to characterize any asymmetry, which helps determine if the asymmetry persists or disappears, and better evaluates the subareolar region if asymmetry/focal asymmetry is present 5, 6
  • Concurrent targeted ultrasound of the area of concern should be performed to identify potentially benign causes of the asymmetry and a target for biopsy if indicated, with a focus on areas that may have suspicious features such as architectural distortion 6
  • If the asymmetry is associated with suspicious microcalcifications, architectural distortion, a palpable abnormality, or new or increasing size compared to prior studies, biopsy is indicated, as recommended by the American College of Radiology 5, 6

Risk Stratification

  • Developing asymmetry has a positive predictive value of 12.8% for cancer at screening and 42.9% when biopsy is recommended, and 23.8% of cancers presenting as developing asymmetry had no sonographic correlate, highlighting the importance of mammographic evaluation 5
  • Low and intermediate-grade DCIS can present as an asymmetry without calcifications, so the absence of calcifications does not exclude malignancy, and biopsy should be considered in cases with suspicious mammographic findings 5

Mammographic Asymmetry Classification and Management

Clinical Significance and Diagnostic Approach

  • The American College of Radiology recommends a BI-RADS classification system to assess breast asymmetries, with developing asymmetry carrying the highest suspicion for malignancy, and having a positive predictive value for cancer of 12.8% at screening and 42.9% when biopsy is ultimately recommended 7
  • For focal asymmetries without temporal change, the malignancy risk is lower but still requires complete workup, with both ductal carcinoma in situ (DCIS) and invasive carcinomas able to manifest as asymmetries 8

Management Based on BI-RADS Assessment

  • The American College of Radiology recommends immediate diagnostic mammography with spot compression views to determine if the asymmetry persists or represents summation artifact, followed by magnification views if associated microcalcifications are present, targeted ultrasound, and BI-RADS classification based on cumulative findings from all imaging modalities 7
  • For BI-RADS 1-3 findings with benign clinical assessment, clinical re-examination in 3-6 months, with follow-up imaging every 6-12 months for 1-2 years to confirm stability, is recommended by the National Comprehensive Cancer Network 8

Management of Breast Asymmetry

Diagnostic Approach

  • The American College of Radiology recommends a BI-RADS Category 0 assessment for incomplete characterization of breast asymmetry, requiring further evaluation to make a final assessment 9
  • Spot compression views are essential to determine whether the asymmetry persists or disappears, indicating summation artifact from overlapping normal breast tissue, as recommended by the American College of Radiology 10, 11

Subsequent Management

  • The American College of Radiology suggests proceeding directly to image-guided core needle biopsy for BI-RADS 4-5 assessment, which indicates suspicious features such as architectural distortion, associated microcalcifications, or correlation with palpable abnormality 12

Diagnostic Mammographic Techniques

Technical Description and Clinical Applications

  • The American College of Radiology and National Comprehensive Cancer Network recommend using a small compression paddle to apply focal compression to a specific area of concern in diagnostic mammography, as described in the spot compression view technique 13, 14

Diagnostic Performance and Guidelines

  • The Italian College of Breast Radiologists and the American College of Radiology note that digital breast tomosynthesis can replace traditional spot compression views in many diagnostic situations, reducing radiation exposure, with an AUC of 0.93 compared to 0.87 for standard mammography plus spot compression magnification (p=0.0014) 15, 16

Digital Breast Tomosynthesis in Diagnostic Mammography

Evidence Supporting DBT

  • The American College of Radiology recommends using diagnostic mammography with tomosynthesis instead of traditional cone compression views, as DBT has been shown to provide equivalent or superior diagnostic accuracy while potentially reducing radiation exposure 17, 18
  • The American College of Radiology confirms that DBT can be used with or without spot compression views in the diagnostic context, and one-view breast tomosynthesis has been demonstrated to be equivalent to or better than supplemental diagnostic mammographic views 17
  • DBT is particularly effective for evaluating masses, asymmetric densities, noncalcified lesions, and screen-detected abnormalities requiring workup 17, 18, 19

Clinical Applications and Radiation Considerations

  • The American College of Radiology suggests that using synthesized 2D images reconstructed from DBT datasets instead of acquiring both standard 2D and DBT images reduces radiation exposure while maintaining diagnostic performance 17, 18, 20
  • The Italian College of Breast Radiologists and ACR support DBT replacing traditional spot compression in most diagnostic situations 17, 18

Practical Implementation and Recommendations

  • The American College of Radiology and other guideline organizations recommend ordering "Diagnostic mammography with digital breast tomosynthesis" instead of "diagnostic mammography with cone compression views" 17, 18, 21
  • The National Comprehensive Cancer Network and the American College of Radiology recommend DBT as standard for diagnostic workup 17, 18, 21

Diagnostic Tomosynthesis Mammogram for Cone Compression Views

Evidence Supporting DBT Over Traditional Cone Compression

  • The American College of Radiology recommends diagnostic digital breast tomosynthesis (DBT) instead of traditional diagnostic digital mammography with spot compression views, as DBT provides equivalent or superior diagnostic accuracy while potentially reducing radiation exposure 22
  • DBT is at least equivalent to additional digital mammography views, such as magnification, spot compression, and 90° views, while also reducing radiation exposure in both diagnostic and screening settings 23, 24, 25

Clinical Applications Where DBT Excels

  • In symptomatic women, DBT improves diagnostic accuracy by reducing the number of suspicious findings and unnecessary biopsies 23, 24, 25
  • For palpable lesions, DBT is never worse and often better than digital mammography for estimating tumor size 23, 24, 25

Radiation Considerations

  • Using synthesized 2D images reconstructed from DBT datasets instead of acquiring both standard 2D and DBT images reduces radiation exposure while maintaining diagnostic performance 22
  • DBT can be used with or without spot compression views in the diagnostic context, and one-view breast tomosynthesis is equivalent to or better than supplemental diagnostic mammographic views 22

Critical Pitfalls to Avoid

  • Always order targeted ultrasound concurrently with diagnostic mammography/DBT to identify potentially benign causes and provide a target for biopsy if indicated 22

When Traditional Cone Compression May Still Be Needed

  • Magnification views remain particularly helpful when evaluating associated microcalcifications 22
  • Interpretation time for DBT images is greater than for standard mammography, but the better diagnostic performance of DBT is confirmed even in challenging cases such as invasive lobular cancers 22, 23, 24, 25

Diagnostic Approach to Mammographic Asymmetry

Introduction to Diagnostic Guidelines

  • The American College of Radiology recommends obtaining tissue diagnosis of the original mammographic asymmetry through stereotactic-guided or tomosynthesis-guided core biopsy when the biopsied mass does not correspond to the asymmetry 26

Diagnostic Procedures

  • The American College of Radiology suggests performing stereotactic-guided or DBT-guided core biopsy of the mammographic asymmetry, using diagnostic mammography with spot compression and magnification views to localize the target, and placing a marker clip at the biopsy site for correlation 26
  • The negative predictive value of combined mammography and ultrasound is only valid when both modalities show concordant benign findings, as stated by the American College of Radiology 27

Clinical Considerations

  • The American College of Radiology advises against assuming the ultrasound biopsy results apply to the mammographic asymmetry, even if the ultrasound-guided biopsy shows benign findings or malignancy, as this does not address the separate mammographic concern 27

Significance of Posterior‑Depth Lesions in Breast Imaging

Epidemiology

  • In the general screening population, approximately 20 % of breast lesions are located more than 3 cm posterior to the nipple, underscoring the need for thorough imaging evaluation of posterior‑depth findings. 28

Imaging Technique Considerations

  • Lesions situated in the posterior depth of the upper outer quadrant are more challenging to visualize on standard mammographic views; therefore, spot‑compression views or digital breast tomosynthesis (DBT) should be employed to achieve adequate characterization. 29

NCCN Guideline Recommendations for Assessment and Management of New Focal Asymmetry on Mammography

BI‑RADS Assessment and Management

  • BI‑RADS 0 is assigned when additional imaging is required before a definitive assessment; the patient should undergo the supplementary views (spot compression, DBT, magnification, or targeted ultrasound) as outlined in the diagnostic work‑up. 30, 31
  • A BI‑RADS 3 (probably benign) assessment may be used only after a complete diagnostic work‑up and should not be applied to screening examinations alone. 30
  • Palpable lesions must not be classified as BI‑RADS 3 because this practice lacks scientific support. 30

Malignancy Risk Associated with BI‑RADS Categories

  • BI‑RADS 4 lesions carry a wide malignancy risk spectrum of approximately 3 % to 94 %. 32, 30
  • BI‑RADS 5 lesions are associated with a malignancy risk of ≥95 %. 32, 30

Advanced Imaging Considerations

  • Magnetic resonance imaging (MRI) may be employed as a problem‑solving tool when mammography and ultrasound findings are nondiagnostic or nonspecific. 32

REFERENCES

1

nccn clinical practice guidelines in oncology: breast cancer screening and diagnosis. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

7

nccn clinical practice guidelines in oncology: breast cancer screening and diagnosis. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

8

nccn clinical practice guidelines in oncology: breast cancer screening and diagnosis. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

9

nccn clinical practice guidelines in oncology: breast cancer screening and diagnosis. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

10

acr appropriateness criteria<sup>®</sup> palpable breast masses. [LINK]

Journal of the American College of Radiology, 2017

11

acr appropriateness criteria<sup>®</sup> palpable breast masses. [LINK]

Journal of the American College of Radiology, 2017

12

acr appropriateness criteria<sup>®</sup> palpable breast masses. [LINK]

Journal of the American College of Radiology, 2017

14

acr appropriateness criteria<sup>®</sup> palpable breast masses. [LINK]

Journal of the American College of Radiology, 2017

17

acr appropriateness criteria<sup>®</sup> palpable breast masses. [LINK]

Journal of the American College of Radiology, 2017

19

acr appropriateness criteria® imaging of invasive breast cancer. [LINK]

Journal of the American College of Radiology, 2024

21
22

acr appropriateness criteria<sup>®</sup> palpable breast masses. [LINK]

Journal of the American College of Radiology, 2017

26

acr appropriateness criteria<sup>®</sup> palpable breast masses. [LINK]

Journal of the American College of Radiology, 2017

27

acr appropriateness criteria<sup>®</sup> palpable breast masses. [LINK]

Journal of the American College of Radiology, 2017

28
29
30

nccn clinical practice guidelines in oncology: breast cancer screening and diagnosis. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

31

nccn clinical practice guidelines in oncology: breast cancer screening and diagnosis. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

32

nccn clinical practice guidelines in oncology: breast cancer screening and diagnosis. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009